BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 32239421)

  • 1. The minor allele of ANGPTL8 rs2278426 has a protective effect against CAD in T2DM patients.
    Bilgin AG; Ekici B; Ozuynuk-Ertugrul AS; Erkan AF; Coban N
    Gene; 2024 Jul; 914():148418. PubMed ID: 38552749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlations between angiopoietin like 8 and cardiometabolic risk factors in Saudi women with type 2 diabetes mellitus: A pilot study.
    Mohammedsaeed W; Binjawhar D
    Diab Vasc Dis Res; 2024; 21(3):14791641241259792. PubMed ID: 38843864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome.
    Mele C; Grugni G; Mai S; Vietti R; Aimaretti G; Scacchi M; Marzullo P
    Sci Rep; 2017 Jun; 7(1):3186. PubMed ID: 28600576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The circulating ANGPTL8 levels show differences among novel subgroups of adult patients with diabetes and are associated with mortality in the subsequent 5 years.
    Zou H; Duan W; Zhang Z; Chen X; Lu P; Yu X
    Sci Rep; 2020 Jul; 10(1):12859. PubMed ID: 32732946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietin-like 8 (ANGPTL8) expression is regulated by miR-143-3p in human hepatocytes.
    DiStefano JK
    Gene; 2019 Jan; 681():1-6. PubMed ID: 30261196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia and ANGPTL8 evaluation in young females with Type 1 diabetes mellitus.
    Mohammedsaeed W; Binjawhar D
    Endocrine; 2024 Jun; ():. PubMed ID: 38836992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of C1q/TNF-α-related protein 6 (CTRP6) in coronary artery disease and its correlation with inflammatory markers.
    Tabatabaei SA; Fadaei R; Moradi N; Farrokhi V; Vatannejad A; Afrisham R; Falahat A; Malekshahi F; Mirahmad M; Abbasi A
    J Diabetes Metab Disord; 2024 Jun; 23(1):1233-1241. PubMed ID: 38932850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multi-faces of Angptl8 in health and disease: Novel functions beyond lipoprotein lipase modulation.
    Abu-Farha M; Ghosh A; Al-Khairi I; Madiraju SRM; Abubaker J; Prentki M
    Prog Lipid Res; 2020 Nov; 80():101067. PubMed ID: 33011191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of traditional obesity parameters in predicting the number of stenosed coronary arteries (≥ 60%) among patients undergoing cardiac catheterization.
    Hayajneh AA; Alhusban IM; Rababa M
    Sci Rep; 2022 Aug; 12(1):13830. PubMed ID: 35970873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANGPTL8 is a negative regulator in pathological cardiac hypertrophy.
    Hu L; Wei J; Zhang Y; Wang Z; Tang J; Tang J; Gao Y; Zhang X; Li Y; Liu Y; Ma S; Guo X; Zhang Q
    Cell Death Dis; 2022 Jul; 13(7):621. PubMed ID: 35851270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between betatrophin/angiogenin-likeprotein3/lipoprotein lipase pathway and severity of coronary artery disease in Kazakh patients with coronary heart disease.
    Qin L; Rehemuding R; Ainiwaer A; Ma X
    World J Clin Cases; 2022 Mar; 10(7):2095-2105. PubMed ID: 35321188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues.
    Zhang R; Zhang K
    Prog Lipid Res; 2022 Jan; 85():101140. PubMed ID: 34793860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches.
    Medina-Leyte DJ; Zepeda-García O; Domínguez-Pérez M; González-Garrido A; Villarreal-Molina T; Jacobo-Albavera L
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and Metabolic Determinants of Plasma Levels of ANGPTL8.
    Oldoni F; Bass K; Kozlitina J; Hudson H; Shihanian LM; Gusarova V; Cohen JC; Hobbs HH
    J Clin Endocrinol Metab; 2021 May; 106(6):1649-1667. PubMed ID: 33619548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher circulating levels of ANGPTL8 are associated with body mass index, triglycerides, and endothelial dysfunction in patients with coronary artery disease.
    Fadaei R; Shateri H; DiStefano JK; Moradi N; Mohammadi M; Emami F; Aghajani H; Ziamajidi N
    Mol Cell Biochem; 2020 Jun; 469(1-2):29-39. PubMed ID: 32239421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between circulating full-length angiopoietin-like protein 8 levels and severity of coronary artery disease in Chinese non-diabetic patients: a case-control study.
    Jiao X; He J; Yang Y; Yang S; Li J; Qin Y
    Cardiovasc Diabetol; 2018 Jun; 17(1):92. PubMed ID: 29940978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between circulating full-length angiopoietin-like protein 8 and non-high-density lipoprotein cholesterol levels in Chinese non-diabetic individuals: a cross-sectional study.
    Yang S; Jiao X; Huo X; Zhu M; Wang Y; Fang X; Yang Y; Yue W; Qin Y
    Lipids Health Dis; 2018 Jul; 17(1):161. PubMed ID: 30021605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein CIII may mediate the impacts of angiopoietin-like protein 8 on triglyceride metabolism.
    Luo M; Su X; Yi Y; Yang Y; Peng D
    Lipids Health Dis; 2018 Jul; 17(1):160. PubMed ID: 30021607
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.